Broadly neutralising antibodies against hepatitis C viruses characterised
Almost a year ago, RESIST researcher Prof. Pietschmann from the Twincore Institute for Experimental Virology and his team developed a test system that can be used to precisely measure the immune response against the broad spectrum of hepatitis C viruses (HCV). With the help of this test system, it has now been possible to isolate HCV antibodies in a study that attack an unusually large number of viral variants simultaneously - so-called broadly neutralizing antibodies. These antibodies reveal where the virus is particularly sensitive, which is another step on the way to developing a hepatitis C vaccine. The study, in [...]









